Moreover, endothelial FABP4 promotion of lipolysis-mediated insulin secretion may be detrimental for β cell health and function, since hyperinsulinemia is a driver for the development of insulin resistance (49). The gene discussed is FABP4; the disease is Hyperinsulinemia.